Company / CapEx per Share
Zymeworks Inc. CapEx per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.02
FY2025
5-year range
$0.02 / $0.24
FY2021-FY2025
Trend
-22.3%
vs FY2024
Sector context
#99 of 192
Health Care
What the data says
At $0.02, Zymeworks Inc.'s capex per share ranks #99 of 192 in the Health Care sector. CapEx per Share has declined for 4 consecutive years, from $0.24 in FY2021 to $0.02 in FY2025.
Based on SEC 10-K filings.
0.02 in FY2025 with a 5-year CAGR of -23.7%.
Declined from $0.04 to $0.02 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -38.0%
- 5-Year CAGR
- -23.7%
- 10-Year CAGR
- -
Sector benchmark
#99 of 192 in Health CareTop 52% of 192This company $0.02 Sector average $3.54
▼
-99.4% below sector average
Key checks
Key Insights
- Zymeworks Inc.'s capex per share has declined for 4 consecutive years.
- In FY2025, capex per share decreased 22.3% year-over-year.
- Ranks #99 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.02 | -22.3% |
| FY2024 | $0.03 | -27.6% |
| FY2023 | $0.04 | -57.6% |
| FY2022 | $0.09 | -61.2% |
| FY2021 | $0.24 | +178.1% |
| FY2020 | $0.09 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026